SEMA7A and cancer: For SEMA3A, SEMA3C, and SEMA7A as well as the semaphorin receptor neuropilin, there was a clear trend where the expression above the cutoff was associated with worse survival for all three cancers (Figures 6, 7C; Supplementary Table 12).